Furthermore, the prompt and effective induction of SARS-CoV-2-specific CD4+ T cells and their presence in circulation within 2–4 days post-symptom onset in acute COVID-19 were associated with mild/moderate COVID-19 and good prognosis [42,43]. This evidence concerns the gene CD4 and COVID-19.